Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Algeria

Algeria: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 12.8% in 2021. ▼ Falling

Latest (2021)
12.8%
Change on year
up 2.4%
World rank
122nd
of 185 countries
All-time high
16.4%
in 2000
All-time low
12.5%
in 2020
Years of data
22
2000–2021

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Algeria, 2000–2021

0510152000201020212000: 16.4 %2001: 16.2 %2002: 16 %2003: 15.8 %2004: 15.6 %2005: 15.4 %2006: 15.2 %2007: 14.9 %2008: 14.7 %2009: 14.4 %2010: 14.1 %2011: 14 %2012: 13.7 %2013: 13.5 %2014: 13.2 %2015: 13.1 %2016: 12.9 %2017: 12.8 %2018: 12.8 %2019: 12.8 %2020: 12.5 %2021: 12.8 %

Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.

Analysis

Algeria recorded 12.8% for mortality from cvd, cancer, diabetes or crd between exact ages 30 and in 2021.

That represents a change of up 2.4% on the previous year and down 8.6% over ten years.

Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Algeria peaked at 16.4% in 2000 and was at its lowest, 12.5%, in 2020.

Algeria ranks 122nd of 185 countries on this measure, in the middle of the range.

The long-run direction has been consistently falling across the 22 years of available data.

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Algeria, year by year

Annual values for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) in Algeria, 2000 to 2021.
Year % Change
2000 16.4%
2001 16.2% -1.2%
2002 16.0% -1.2%
2003 15.8% -1.2%
2004 15.6% -1.3%
2005 15.4% -1.3%
2006 15.2% -1.3%
2007 14.9% -2.0%
2008 14.7% -1.3%
2009 14.4% -2.0%
2010 14.1% -2.1%
2011 14.0% -0.7%
2012 13.7% -2.1%
2013 13.5% -1.5%
2014 13.2% -2.2%
2015 13.1% -0.8%
2016 12.9% -1.5%
2017 12.8% -0.8%
2018 12.8% +0.0%
2019 12.8% +0.0%
2020 12.5% -2.3%
2021 12.8% +2.4%

Algeria compared with similar countries

  • Algeria's 12.8% is below the median for upper middle income countries, which is 15.1%, 85% of the median. (55 countries reporting)
  • Algeria's 12.8% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 13.3%, 96% of the median. (23 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 15.5% 14.4% 16.4% 10
2010s 13.3% 12.8% 14.1% 10
2020s 12.7% 12.5% 12.8% 2

Countries ranked near Algeria

  1. 119 Viet Nam 13.1% compare
  2. 120 Belarus 13.0% compare
  3. 120 Brunei Darussalam 13.0% compare
  4. 122 Georgia 12.8% compare
  5. 122 Peru 12.8% compare
  6. 125 Iran, Islamic Republic of 12.7% compare

See the full ranking of 232 places →

More health data for Algeria

All data for Algeria →

Frequently asked questions

What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Algeria?
Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Algeria was 12.8% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Algeria?
The highest recorded value was 16.4% in 2000.
What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Algeria?
The lowest recorded value was 12.5% in 2020.
How does Algeria rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
Algeria ranks 122nd out of 185 countries with data for 2021.
Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Algeria?
Over the last ten years it is down 8.6%. The long-run trend across the full record is falling.
Where does this Algeria data come from?
The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Algeria. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 14 September 2026, from https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-female-percent/algeria/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-female-percent/algeria/">Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Algeria</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).